drugset / Trial / NCT02797587

Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)

NCT02797587

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a randomized controlled trial (RCT) to compare the effects of varenicline, cytisine, and nicotine replacement therapy (NRT) to reduce: 1) alcohol use and craving, 2) smoking; and 3) inflammation and risk for coronary heart disease (CHD) and mortality among 400 HIV-infected Russians, with heavy alcohol consumption and tobacco use.

Timeline

Start
2017-07-19
Primary completion
2020-04-30
Completion
2020-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cytisinicline Small molecule 3 mg
Comparator Cytisinicline Small molecule 9 mg
Comparator Varenicline Small molecule 1 mg